These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34448667)

  • 1. Determinants of market prices for drugs under Japan's national health insurance.
    Mamiya H; Igarashi A
    J Med Econ; 2021; 24(1):1109-1114. PubMed ID: 34448667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan.
    Mamiya H; Igarashi A
    J Med Econ; 2022; 25(1):206-211. PubMed ID: 35060813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prices for generics in Australia - more competition might help.
    Bulfone L
    Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influences of Taiwan's generic grouping price policy on drug prices and expenditures: evidence from analysing the consumption of the three most-used classes of cardiovascular drugs.
    Chen CL; Chen L; Yang WC
    BMC Public Health; 2008 Apr; 8():118. PubMed ID: 18405385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition.
    Dickson SR; Kent T
    JAMA Netw Open; 2021 Nov; 4(11):e2133451. PubMed ID: 34779844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs Targeted for Price Cutting in Japan: The Case of Price Revisions Based on the Divergence of Official Versus Delivery Prices.
    Fukumoto D; Tsuyuki A; Suzuki T
    Ther Innov Regul Sci; 2017 Sep; 51(5):597-603. PubMed ID: 30231688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan.
    Maeda H; Okabe A; Sakakura K; Ng DB; Akazawa M
    BMC Health Serv Res; 2021 Dec; 21(1):1329. PubMed ID: 34895223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of European pharmaceutical price regulation on generic price competition: a review.
    Puig-Junoy J
    Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An empirical study of the impact of generic drug competition on drug market prices in China.
    Yina C; Pengcheng L; Haomiao N; Yang C
    Front Public Health; 2023; 11():1146531. PubMed ID: 37304112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy.
    Spinks J; Chen G; Donovan L
    Aust Health Rev; 2013 Nov; 37(5):675-81. PubMed ID: 24160374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of drug prices: a systematic review of comparison studies.
    Janssen Daalen JM; den Ambtman A; Van Houdenhoven M; van den Bemt BJF
    BMJ Open; 2021 Jul; 11(7):e046917. PubMed ID: 34266841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.
    Dave CV; Kesselheim AS; Fox ER; Qiu P; Hartzema A
    Ann Intern Med; 2017 Aug; 167(3):145-151. PubMed ID: 28672324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs.
    Takayama A; Narukawa M
    Ther Innov Regul Sci; 2016 May; 50(3):361-367. PubMed ID: 30227073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.